MedPath

The Impact of Grand Tour Cycling on Sleep and the Hematological and Metabolomic Profile in World-class Cyclists

Conditions
Overreaching
Interventions
Other: Cyclist
Registration Number
NCT06386900
Lead Sponsor
KU Leuven
Brief Summary

This project aims to identify the effect of a 3-week Grand Tour (e.g. Tour de France, Giro d'Italia, and Vuelta a España) on sleep, hematological parameters and the serum metabolome in world-class cyclists.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
Male
Target Recruitment
16
Inclusion Criteria
  • Cylist participating in a Grand Tour (e.g. Tour de France, Vuelta a España, Giro d'Italia)
Exclusion Criteria
  • /

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Elite cyclists participating in a Grand TourCyclist* Sleep metrics will be tracked by a smart ring (OURA Gen3, OURA Health Ltd, Oulu, Finland) starting from one month prior to the start till the end of the Grand Tour * Nocturnal heart rate and heart rate variability will be collected by a smart ring (OURA Gen3, OURA Health Ltd, Oulu, Finland) starting from one month prior till the end of the Grand Tour * Fasted whole blood samples and urine samples will be collected on the morning of (i) the first stage, (ii) the first restday, (iii) second restday, and (iv) last stage of the GrandTour (only in one Grand Tour for a total of 8 cyclists).
Primary Outcome Measures
NameTimeMethod
Sleep efficiency during the Grand TourEvery night starting from one week before till the last night of the Grand Tour

Percentage change in sleep efficiency during the Grand Tour (measured by OURA ring)

Total sleep time during the Grand TourEvery night starting from one week before till the last night of the Grand Tour

Change in total sleep time during the Grand Tour (measured by OURA ring)

Blood haemoglobin concentrationStart of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand Tour

Change in the blood haemoglobin concentration during the Grand Tour

Serum metabolome abundance of cyclists participating in a Grand TourStart of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand Tour

Changes in the abundance of serum metabolites within the cyclists between 4 timepoints (measured by mass spectrometry)

Secondary Outcome Measures
NameTimeMethod
Light sleepBefore the start of the Tour - restday 1 - restday 2 - end of Grand Tour

Percentage change in light sleep during the Grand Tour (measured by OURA ring)

REM sleepBefore the start of the Tour - restday 1 - restday 2 - end of Grand Tour

Percentage change in REM sleep during the Grand Tour (measured by OURA ring)

Deep sleepBefore the start of the Tour - restday 1 - restday 2 - end of Grand Tour

Percentage change in deep sleep during the Grand Tour (measured by OURA ring)

Wakefulness after sleep onsetEvery night starting from one week before till the last night of the Grand Tour

Percentage change in wakefulness after sleep onset during the Grand Tour (measured by OURA ring)

Red blood cell concentrationStart of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand Tour

Change in red blood cell concentration during the Grand Tour

Subjective fatigueStart of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand Tour

Absolute change in subjective fatigue during the Grand Tour (measured by 11-point scale)

Trial Locations

Locations (1)

KU Leuven

🇧🇪

Leuven, Vlaams-Brabant, Belgium

© Copyright 2025. All Rights Reserved by MedPath